New data show benefit of DaTSCAN™ (Ioflupane I 123 Injection) in the diagnosis of patients with clinically uncertain dementia with Lewy bodies

Written on:October 1, 2013
Comments are closed

Data presented at the XXI World Congress of Neurology in Vienna suggest that DaTSCAN™ (Ioflupane I 123 Injection) SPECT imaging could add value to current diagnostic tools used by physicians to diagnose patients with dementia with Lewy bodies (DLB) by improving physician’s ability to definitively diagnose the disorder and increase their confidence in so doing…

Source: Medical Devices


Sorry, the comment form is closed at this time.